PETROS STREMPAS

Dr. PETROS STREMPAS

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
TLTheano Lagousi
Theano Lagousi
IPIoanna Papadatou
Ioanna Papadatou
PSPETROS STREMPAS
PETROS STREMPAS
ECElena Chatzikalil
Elena Chatzikalil
VSVana Spoulou
Vana Spoulou
Despite the significant reduction in pneumococcal disease due to pneumococcal vaccines, protection of vulnerable high-risk individuals, especially pediatric populations, remains a great challenge. In an effort to maximize the protection of high-risk children against pneumococcal disease, a combined schedule that includes both conjugate and polysaccharide vaccines is recommended by several countries in the developed world. On the other hand, middle- and low-income countries do not have in place established policies for pneumococcal immunization of children at risk. Pneumococcal conjugate vaccines, despite their benefits, have several limitations, mainly associated with serotype replacement and the wide range of serotype coverage worldwide. In addition, PPV23-impaired immunogenicity and the hyporesponsiveness effect among populations at risk have been well-documented. Therefore, the added value of continuing to include PPV23 in vaccination schedules for high-risk individuals in the years to come remains to be determined by monitoring whether the replacing/remaining serotypes causing IPD are covered by PPV23 to determine whether its benefits outweigh its limitations. In this review, we aim to describe serotype distribution and vaccine efficacy data on pneumococcal disease in the pre- and post-PCV implementation era among high-risk children in both developed and developing countries, assessing the optimization of current recommendations for their vaccination against pneumococcal disease.

29 March 2025 in Children
Verified
Journal Article
Open access
PDF file
PSPETROS STREMPAS
PETROS STREMPAS
HWHeidi Weberruss
Heidi Weberruss
TBThomas Bollinger
Thomas Bollinger
TRThomas Rupprecht
Thomas Rupprecht
Background: Respiratory tract infections (RTIs) represent a frequent cause of inpatient admission in children’s hospitals, especially in the fall and winter seasons, resulting in major healthcare problems due to a lack of beds. The age and seasonal distribution of each pathogen seem to be multifactorial features that influence the course of infection. Other severity predictors appear to be the length of hospital stay, the presence or absence of oxygen demand, and the value of inflammatory markers. Methods: All inpatients from our children’s hospital between 2021 and 2023 who had a nasopharyngeal swab and presented with RTI symptoms were recruited for this retrospective cohort study. The parameters of interest were age, swab result, month of detection, CRP values, duration of hospitalization, presence of oxygen demand, and comorbidities. The data were analyzed using chi-square tests, paired t-tests and regression analysis to determine the associations of differences between the groups. Results: Detection of more than one respiratory pathogen in the same swab, apart from combinations with SARA-CoV-2, influenza, or RS-virus, was not associated with longer hospital stay, higher mean maximal CRP values, or oxygen demand compared to mono-infection with the same pathogens. In contrast, the detection of a pathogen versus no detection could be related to higher rates of oxygen demand and higher CRP values. Conclusions: Since co-infection with more than one virus, excluding those with epidemic potential, was not associated with a more severe course of RTIs, strict patient isolation seems to be dispensable for several viruses, as well as isolation of infected or colonized patients.

1 January 2026 in Case Reports in Pediatrics
Verified
Journal Article
Open access
PDF file
PMPatrick Morhart
Patrick Morhart
SMSergio Antonio Maravilla-Galdamez
Sergio Antonio Maravilla-Galdamez
PSPETROS STREMPAS
PETROS STREMPAS
TBThomas Bollinger
Thomas Bollinger
TKThomas Kienbaum
Thomas Kienbaum
HWHeidi Weberruß
Heidi Weberruß
Neonatal isolated submandibular suppurative sialadenitis (NISSS) is a rare condition. We present a case of NISSS caused by Staphylococcus aureus ( S. aureus ) in premature triplet girls born at 28 + 1 weeks of gestation. Mother’s milk culture tested positive for S. aureus , which is presumed to be the potential contributing factor of the infection. The first symptoms appeared in one of the girls at 31 days of age, followed by her sisters at 34 and 36 days of age, respectively. A search of the PubMed/Medline, ScienceDirect and Web of Science databases revealed that this is the first reported case of NISSS in triplets. We defined risk factors like an immature immune system, prolonged orogastric feeding and antidiuretic therapy for developing NISSS in neonates.